2 false false false false false false false false false false true false false false false false true No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 11453792 2025-04-01 2026-03-31 11453792 2026-03-31 11453792 2025-03-31 11453792 2024-04-01 2025-03-31 11453792 2025-03-31 11453792 2024-03-31 11453792 bus:Director1 2025-04-01 2026-03-31 11453792 core:WithinOneYear 2026-03-31 11453792 core:WithinOneYear 2025-03-31 11453792 bus:Micro-entities 2025-04-01 2026-03-31 11453792 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 11453792 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 11453792 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11453792 bus:FullAccounts 2025-04-01 2026-03-31
COMPANY REGISTRATION NUMBER: 11453792
DR Nasr Healthcare Limited
Filleted Unaudited Financial Statements
31 March 2026
DR Nasr Healthcare Limited
Statement of Financial Position
31 March 2026
2026
2025
£
£
Current assets
347,866
267,004
Prepayments and accrued income
3,086
2,777
---------
---------
350,952
269,781
Creditors: amounts falling due within one year
50,511
49,765
---------
---------
Net current assets
300,441
220,016
---------
---------
Total assets less current liabilities
300,441
220,016
Accruals and deferred income
1,700
1,700
---------
---------
298,741
218,316
---------
---------
Capital and reserves
298,741
218,316
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2025: 2 ).
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 25 August 2026 , and are signed on behalf of the board by:
Dr A. Nasr
Director
Company registration number: 11453792
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 60 Foxes Meadow, Birmingham, West Midlands, B30 1BQ.